🚀 VC round data is live in beta, check it out!
Agfa-Gevaert Valuation Multiples
Discover revenue and EBITDA valuation multiples for Agfa-Gevaert and similar public comparables like Fractyl Health, Stokvis Nord Africa Ste SA, Actia, Optiscan Imaging and more.
Agfa-Gevaert Overview
About Agfa-Gevaert
Agfa-Gevaert NV develops, produces, and distributes a range of analog and digital imaging systems and information technology solutions, for the printing sector, healthcare sector, and specific industrial applications. The company's operating segment includes CONOPS; Digital Print and Chemicals; Radiology Solutions and Healthcare IT. It generates maximum revenue from the Digital Print and Chemicals segment. The company operates in Europe, NAFTA, Latin America and Asia/Oceania/Africa.
Founded
1964
HQ
Employees
4.8K
Website
Financials (LTM)
EV
$180M
Agfa-Gevaert Financials
Agfa-Gevaert reported last 12-month revenue of $1B and EBITDA of $69M.
In the same LTM period, Agfa-Gevaert generated $378M in gross profit, $69M in EBITDA, and had net loss of ($36M).
Revenue (LTM)
Agfa-Gevaert P&L
In the most recent fiscal year, Agfa-Gevaert reported revenue of $1B and EBITDA of $68M.
Agfa-Gevaert expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | XXX | $1B | XXX | XXX | XXX |
| Gross Profit | $378M | XXX | $386M | XXX | XXX | XXX |
| Gross Margin | 30% | XXX | 30% | XXX | XXX | XXX |
| EBITDA | $69M | XXX | $68M | XXX | XXX | XXX |
| EBITDA Margin | 5% | XXX | 5% | XXX | XXX | XXX |
| EBIT Margin | 2% | XXX | 2% | XXX | XXX | XXX |
| Net Profit | ($36M) | XXX | ($45M) | XXX | XXX | XXX |
| Net Margin | (3%) | XXX | (3%) | XXX | XXX | XXX |
| Net Debt | — | — | $24M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Agfa-Gevaert Stock Performance
Agfa-Gevaert has current market cap of $88M, and enterprise value of $180M.
Market Cap Evolution
Agfa-Gevaert's stock price is $0.57.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $180M | $88M | 0.0% | XXX | XXX | XXX | $-0.29 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAgfa-Gevaert Valuation Multiples
Agfa-Gevaert trades at 0.1x EV/Revenue multiple, and 2.6x EV/EBITDA.
EV / Revenue (LTM)
Agfa-Gevaert Financial Valuation Multiples
As of April 20, 2026, Agfa-Gevaert has market cap of $88M and EV of $180M.
Equity research analysts estimate Agfa-Gevaert's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Agfa-Gevaert has a P/E ratio of (2.5x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $88M | XXX | $88M | XXX | XXX | XXX |
| EV (current) | $180M | XXX | $180M | XXX | XXX | XXX |
| EV/Revenue | 0.1x | XXX | 0.1x | XXX | XXX | XXX |
| EV/EBITDA | 2.6x | XXX | 2.6x | XXX | XXX | XXX |
| EV/EBIT | 6.7x | XXX | 6.8x | XXX | XXX | XXX |
| EV/Gross Profit | 0.5x | XXX | 0.5x | XXX | XXX | XXX |
| P/E | (2.5x) | XXX | (2.0x) | XXX | XXX | XXX |
| EV/FCF | 32.8x | XXX | 5.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Agfa-Gevaert Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Agfa-Gevaert Margins & Growth Rates
Agfa-Gevaert's revenue in the last 12 month grew by 1%.
Agfa-Gevaert's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Agfa-Gevaert's rule of 40 is 4% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Agfa-Gevaert's rule of X is 3% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Agfa-Gevaert Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | (1%) | XXX | XXX | XXX |
| EBITDA Margin | 5% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 2% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 4% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 3% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 14% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 11% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 29% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Agfa-Gevaert Public Comps
See public comps and valuation multiples for other Medical Devices and Industrial Parts comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Agfa-Gevaert | XXX | XXX | XXX | XXX | XXX | XXX |
| Fractyl Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Stokvis Nord Africa Ste SA | XXX | XXX | XXX | XXX | XXX | XXX |
| Actia | XXX | XXX | XXX | XXX | XXX | XXX |
| Optiscan Imaging | XXX | XXX | XXX | XXX | XXX | XXX |
| Kwangmu | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Agfa-Gevaert M&A Activity
Agfa-Gevaert acquired XXX companies to date.
Last acquisition by Agfa-Gevaert was on XXXXXXXX, XXXXX. Agfa-Gevaert acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Agfa-Gevaert
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAgfa-Gevaert Investment Activity
Agfa-Gevaert invested in XXX companies to date.
Agfa-Gevaert made its latest investment on XXXXXXXX, XXXXX. Agfa-Gevaert invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Agfa-Gevaert
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Agfa-Gevaert
| When was Agfa-Gevaert founded? | Agfa-Gevaert was founded in 1964. |
| Where is Agfa-Gevaert headquartered? | Agfa-Gevaert is headquartered in Belgium. |
| How many employees does Agfa-Gevaert have? | As of today, Agfa-Gevaert has over 4K employees. |
| Who is the CEO of Agfa-Gevaert? | Agfa-Gevaert's CEO is Pascal Juery. |
| Is Agfa-Gevaert publicly listed? | Yes, Agfa-Gevaert is a public company listed on Euronext Brussels. |
| What is the stock symbol of Agfa-Gevaert? | Agfa-Gevaert trades under AGFB ticker. |
| When did Agfa-Gevaert go public? | Agfa-Gevaert went public in 1999. |
| Who are competitors of Agfa-Gevaert? | Agfa-Gevaert main competitors are Fractyl Health, Stokvis Nord Africa Ste SA, Actia, Optiscan Imaging. |
| What is the current market cap of Agfa-Gevaert? | Agfa-Gevaert's current market cap is $88M. |
| What is the current revenue of Agfa-Gevaert? | Agfa-Gevaert's last 12 months revenue is $1B. |
| What is the current revenue growth of Agfa-Gevaert? | Agfa-Gevaert revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of Agfa-Gevaert? | Current revenue multiple of Agfa-Gevaert is 0.1x. |
| Is Agfa-Gevaert profitable? | Yes, Agfa-Gevaert is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Agfa-Gevaert? | Agfa-Gevaert's last 12 months EBITDA is $69M. |
| What is Agfa-Gevaert's EBITDA margin? | Agfa-Gevaert's last 12 months EBITDA margin is 5%. |
| What is the current EV/EBITDA multiple of Agfa-Gevaert? | Current EBITDA multiple of Agfa-Gevaert is 2.6x. |
| What is the current FCF of Agfa-Gevaert? | Agfa-Gevaert's last 12 months FCF is $5M. |
| What is Agfa-Gevaert's FCF margin? | Agfa-Gevaert's last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of Agfa-Gevaert? | Current FCF multiple of Agfa-Gevaert is 32.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.